Article

The prognostic value of KRAS mutation in locally advanced rectal cancer.

2022-03-07

Abstract excerpt

<h4>Background: </h4> The prognostic value of the KRAS proto-oncogene mutation in colorectal cancer has been debated. Herein, we analyzed the National Cancer Database (NCDB) to assess the role of KRAS mutation as a prognostic marker in patients with locally advanced rectal cancer (LARC). <h4>Methods: </h4> We identified LARC patients treated with neoadjuvant chemoradiation from 2004-2015 excluding those with stage...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e943e3a-eabf-5086-8b07-916c38b1b7fc
DOI: 10.21203/rs.3.rs-1413877/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The prognostic value of KRAS mutation in locally advanced rectal cancer.DOI 10.21203/rs.3.rs-1413877/v1Read

The prognostic value of KRAS mutation in locally advanced rectal cancer.Semantic proximity Read

KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.Semantic proximity Read

The effects of KRAS Mutations on the Prognosis of Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Surgery.Semantic proximity Read

Effect of KRAS mutation status on clinicopathological characteristics and over survival in patients wtih rectal cancerSemantic proximity Read

Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.Semantic proximity Read

KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.Semantic proximity Read

Prognostic Value of KRAS Mutations in Colorectal Cancer PatientsSemantic proximity Read

Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.Semantic proximity Read

Prognostic and Predictive Roles of KRAS Mutation in Colorectal CancerSemantic proximity Read

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.Semantic proximity Read

Influence of KRAS mutation subtypes on response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: meta-analysis.Semantic proximity Read

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.Semantic proximity Read